EUGMP require MAH holders to ensure excipients are suitable to use in pharmaceutical products
- Perform formalised risk assessment of Excipients with respect to safety, quality and function of each excipient in a drug product
- Risk Assessment of Excipient based on
- Source – Source Risk Assessment
- Function of the excipient in the drug product, covering all drug products in which the excipient is used – Functional Risk Assessment
- Ascertain Appropriate GMPs applicable for the Excipient based on risk level
- Fundamental GMP Elements
- Additional GMP elements
- Perform GMP Gap Analysis
- Generate Excipient Control Strategy
Follows Guidance for Risk Assessment for Ascertaining the Appropriate Good Manufacturing Practice for Excipients of Medicinal Products for Human Use (EU 2015/C 95/02)
Click here for Qvents Excipient Risk Assessment Tool
Leave a Comment
You must be logged in to post a comment.